Ensysce Biosciences logo

Ensysce Biosciences Share Price Today

(NASDAQ: ENSC)

Ensysce Biosciences share price is $5.11 & ₹444.41 as on 6 Mar 2025, 2.30 'hrs' IST

$5.11

-0.3

(-5.62%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Ensysce Biosciences share price in Dollar and Rupees. Guide to invest in Ensysce Biosciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Ensysce Biosciences, along with analyst recommendations, forecasts, and comprehensive financials.

Ensysce Biosciences share price movements

  • Today's Low: $4.99
    Today's High: $5.29

    Day's Volatility :5.64%

  • 52 Weeks Low: $2.12
    52 Weeks High: $14.67

    52 Weeks Volatility :85.56%

Ensysce Biosciences (ENSC) Returns

PeriodEnsysce Biosciences IncIndex (Russel 2000)
3 Months
-29.51%
0.0%
6 Months
-9.23%
0.0%
1 Year
-57.19%
0.0%
3 Years
-99.85%
-11.6%

Ensysce Biosciences (ENSC) Key Statistics

in dollars & INR

Previous Close
$5.41
Open
$5.28
Today's High
$5.29
Today's Low
$4.9916
Market Capitalization
$7.1M
Today's Volume
$15.3K
52 Week High
$14.67
52 Week Low
$2.118
Revenue TTM
$4.4M
EBITDA
$-24.2M
Earnings Per Share (EPS)
$-29.21
Profit Margin
-179.26%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-204.9%

How to invest in Ensysce Biosciences Stock (ENSC) from India?

It is very easy for Indian residents to invest directly in Ensysce Biosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Ensysce Biosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Ensysce Biosciences or ENSC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Ensysce Biosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Ensysce Biosciences shares which would translate to 0.170 fractional shares of Ensysce Biosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Ensysce Biosciences, in just a few clicks!

Returns in Ensysce Biosciences (ENSC) for Indian investors in Rupees

The Ensysce Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Ensysce Biosciences investment value today

Current value as on today

₹47,782

Returns

₹52,218

(-52.22%)

Returns from Ensysce Biosciences Stock

₹57,167 (-57.17%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Ensysce Biosciences (ENSC)

-22%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Ensysce Biosciences Stock from India on INDmoney has decreased by -22% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Ensysce Biosciences

  • Perceptive Advisors LLC

    6.64%

  • Adage Capital Partners Gp LLC

    3.83%

  • FNY Investment Advisers, LLC

    0.23%

  • UBS Group AG

    0.05%

  • Tower Research Capital LLC

    0.03%

Analyst Recommendation on Ensysce Biosciences

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Ensysce Biosciences(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Ensysce Biosciences Stock (ENSC)

What analysts predicted

Upside of 922.5%

Target:

$52.25

Current:

$5.11

Insights on Ensysce Biosciences Stock (Ticker Symbol: ENSC)

  • Price Movement

    In the last 3 years, ENSC stock has moved down by -99.9%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 515.03K → 181.79K (in $), with an average decrease of 40.6% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 4 quarters, -3.50M → 661.76K (in $), with an average increase of 156.1% per quarter
  • ENSC vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 123.7%
  • ENSC vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 151.5%
  • Price to Sales

    ForENSC every $1 of sales, investors are willing to pay $0.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Ensysce Biosciences Technicals Summary

Sell

Neutral

Buy

Ensysce Biosciences is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Ensysce Biosciences (ENSC) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Ensysce Biosciences Inc logo
-18.83%
-9.23%
-57.19%
-99.85%
-99.99%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Ensysce Biosciences Inc logo
NA
NA
NA
-12.45
-2.05
-0.63
NA
7.47
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Ensysce Biosciences Inc logo
Buy
$7.1M
-99.99%
NA
-179.26%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Ensysce Biosciences

Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection (TAAP) platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abuse Resistance (MPAR) platform, an over-dose protection opioid prodrug technology. The company is developing PF614, a TAAP oxycodone prodrug candidate for the treatment of acute or chronic pain; and PF614-MPAR, a combination product of PF614 and nafamostat for overdose protection against excessive oral ingestion, as well as an oral and inhalation drug product of nafamostat for use against coronaviral infections and other pulmonary diseases, such as cystic fibrosis. It is also developing PF614, an extended-release oxycodone-derivative that releases clinically effective oxycodone; PF329 for pain with abuse protection; PF8001 and PF8026 are extended and immediate-release prodrugs of amphetamine for ADHD; and PF9001 to treat Opioid use disorder. The company was founded in 2003 and is based in La Jolla, California.
Organization
Ensysce Biosciences
Employees
7
CEO
Dr. D. Lynn Kirkpatrick Ph.D.
Industry
Miscellaneous

Management People of Ensysce Biosciences

NameTitle
Dr. D. Lynn Kirkpatrick Ph.D.
President, CEO & Director
Mr. David C. Humphrey CPA
CFO, Secretary & Treasurer
Mr. Geoffrey Birkett
Chief Commercial Officer
Dr. Jeffrey Millard Ph.d.
Chief Operating Officer
Dr. William K. Schmidt Ph.D.
Chairman of Clinical Advisory Board & Chief Medical Officer
Dr. Linda Pestano Ph.D.
Chief Development Officer

Important FAQs about investing in ENSC Stock from India :

What is Ensysce Biosciences share price today?

Ensysce Biosciences share price today stands at $5.11, Open: $5.28 ; Previous Close: $5.41 ; High: $5.29 ; Low: $4.99 ; 52 Week High: $14.67 ; 52 Week Low: $2.12.

The stock opens at $5.28, after a previous close of $5.41. The stock reached a daily high of $5.29 and a low of $4.99, with a 52-week high of $14.67 and a 52-week low of $2.12.

Can Indians buy Ensysce Biosciences shares?

Yes, Indians can invest in the Ensysce Biosciences (ENSC) from India.

With INDmoney, you can buy Ensysce Biosciences at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Ensysce Biosciences at zero transaction cost.

How can I buy Ensysce Biosciences shares from India?

It is very easy to buy Ensysce Biosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Ensysce Biosciences (ENSC) be purchased?

Yes, you can buy fractional shares of Ensysce Biosciences with INDmoney app.

What are the documents required to start investing in Ensysce Biosciences stocks?

To start investing in Ensysce Biosciences, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Ensysce Biosciences Stock (ENSC)?

Today’s highest price of Ensysce Biosciences (ENSC) is $5.29.

Today’s lowest price of Ensysce Biosciences (ENSC) is $4.99.

What is today's market capitalisation of Ensysce Biosciences?

Today's market capitalisation of Ensysce Biosciences ENSC is 7.1M

What is the 52 Week High and Low Range of Ensysce Biosciences Stock (ENSC)?

  • 52 Week High

    $14.67

  • 52 Week Low

    $2.12

What are the historical returns of Ensysce Biosciences (ENSC)?

  • 1 Month Returns

    -18.83%

  • 3 Months Returns

    -9.23%

  • 1 Year Returns

    -57.19%

  • 5 Years Returns

    -99.99%

Who is the Chief Executive Officer (CEO) of Ensysce Biosciences ?

Dr. D. Lynn Kirkpatrick Ph.D. is the current Chief Executive Officer (CEO) of Ensysce Biosciences.